Drug
Las 41002
Las 41002: highest development phase Phase 2, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAS 41002 NCT01119313 | Phase 2 | Atopic Eczema |
Latest
No recent events.
Follow Las 41002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.